297 related articles for article (PubMed ID: 21798848)
1. Genome-wide molecular characterization of central nervous system primitive neuroectodermal tumor and pineoblastoma.
Miller S; Rogers HA; Lyon P; Rand V; Adamowicz-Brice M; Clifford SC; Hayden JT; Dyer S; Pfister S; Korshunov A; Brundler MA; Lowe J; Coyle B; Grundy RG
Neuro Oncol; 2011 Aug; 13(8):866-79. PubMed ID: 21798848
[TBL] [Abstract][Full Text] [Related]
2. DNA copy number alterations in central primitive neuroectodermal tumors and tumors of the pineal region: an international individual patient data meta-analysis.
von Bueren AO; Gerss J; Hagel C; Cai H; Remke M; Hasselblatt M; Feuerstein BG; Pernet S; Delattre O; Korshunov A; Rutkowski S; Pfister SM; Baudis M
J Neurooncol; 2012 Sep; 109(2):415-23. PubMed ID: 22772606
[TBL] [Abstract][Full Text] [Related]
3. Loss of INI1 protein expression defines a subgroup of aggressive central nervous system primitive neuroectodermal tumors.
Miller S; Ward JH; Rogers HA; Lowe J; Grundy RG
Brain Pathol; 2013 Jan; 23(1):19-27. PubMed ID: 22672440
[TBL] [Abstract][Full Text] [Related]
4. p18Ink4c and p53 Act as tumor suppressors in cyclin D1-driven primitive neuroectodermal tumor.
Saab R; Rodriguez-Galindo C; Matmati K; Rehg JE; Baumer SH; Khoury JD; Billups C; Neale G; Helton KJ; Skapek SX
Cancer Res; 2009 Jan; 69(2):440-8. PubMed ID: 19147556
[TBL] [Abstract][Full Text] [Related]
5. MRI Features of Histologically Diagnosed Supratentorial Primitive Neuroectodermal Tumors and Pineoblastomas in Correlation with Molecular Diagnoses and Outcomes: A Report from the Children's Oncology Group ACNS0332 Trial.
Jaju A; Hwang EI; Kool M; Capper D; Chavez L; Brabetz S; Billups C; Li Y; Fouladi M; Packer RJ; Pfister SM; Olson JM; Heier LA
AJNR Am J Neuroradiol; 2019 Nov; 40(11):1796-1803. PubMed ID: 31601576
[TBL] [Abstract][Full Text] [Related]
6. Pineoblastoma segregates into molecular sub-groups with distinct clinico-pathologic features: a Rare Brain Tumor Consortium registry study.
Li BK; Vasiljevic A; Dufour C; Yao F; Ho BLB; Lu M; Hwang EI; Gururangan S; Hansford JR; Fouladi M; Nobusawa S; Laquerriere A; Delisle MB; Fangusaro J; Forest F; Toledano H; Solano-Paez P; Leary S; Birks D; Hoffman LM; Szathmari A; Faure-Conter C; Fan X; Catchpoole D; Zhou L; Schultz KAP; Ichimura K; Gauchotte G; Jabado N; Jones C; Loussouarn D; Mokhtari K; Rousseau A; Ziegler DS; Tanaka S; Pomeroy SL; Gajjar A; Ramaswamy V; Hawkins C; Grundy RG; Hill DA; Bouffet E; Huang A; Jouvet A
Acta Neuropathol; 2020 Feb; 139(2):223-241. PubMed ID: 31820118
[TBL] [Abstract][Full Text] [Related]
7. An investigation of WNT pathway activation and association with survival in central nervous system primitive neuroectodermal tumours (CNS PNET).
Rogers HA; Miller S; Lowe J; Brundler MA; Coyle B; Grundy RG
Br J Cancer; 2009 Apr; 100(8):1292-302. PubMed ID: 19293793
[TBL] [Abstract][Full Text] [Related]
8. Gene amplification in PNETs/medulloblastomas: mapping of a novel amplified gene within the MYCN amplicon.
Frühwald MC; O'Dorisio MS; Rush LJ; Reiter JL; Smiraglia DJ; Wenger G; Costello JF; White PS; Krahe R; Brodeur GM; Plass C
J Med Genet; 2000 Jul; 37(7):501-9. PubMed ID: 10882752
[TBL] [Abstract][Full Text] [Related]
9. Treatment of young children with CNS-primitive neuroectodermal tumors/pineoblastomas in the prospective multicenter trial HIT 2000 using different chemotherapy regimens and radiotherapy.
Friedrich C; von Bueren AO; von Hoff K; Gerber NU; Ottensmeier H; Deinlein F; Benesch M; Kwiecien R; Pietsch T; Warmuth-Metz M; Faldum A; Kuehl J; Kortmann RD; Rutkowski S
Neuro Oncol; 2013 Feb; 15(2):224-34. PubMed ID: 23223339
[TBL] [Abstract][Full Text] [Related]
10. Mutations in the human homologue of the Drosophila segment polarity gene patched (PTCH) in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system.
Wolter M; Reifenberger J; Sommer C; Ruzicka T; Reifenberger G
Cancer Res; 1997 Jul; 57(13):2581-5. PubMed ID: 9205058
[TBL] [Abstract][Full Text] [Related]
11. CNS-PNETs with C19MC amplification and/or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entity.
Spence T; Sin-Chan P; Picard D; Barszczyk M; Hoss K; Lu M; Kim SK; Ra YS; Nakamura H; Fangusaro J; Hwang E; Kiehna E; Toledano H; Wang Y; Shi Q; Johnston D; Michaud J; La Spina M; Buccoliero AM; Adamek D; Camelo-Piragua S; Peter Collins V; Jones C; Kabbara N; Jurdi N; Varlet P; Perry A; Scharnhorst D; Fan X; Muraszko KM; Eberhart CG; Ng HK; Gururangan S; Van Meter T; Remke M; Lafay-Cousin L; Chan JA; Sirachainan N; Pomeroy SL; Clifford SC; Gajjar A; Shago M; Halliday W; Taylor MD; Grundy R; Lau CC; Phillips J; Bouffet E; Dirks PB; Hawkins CE; Huang A
Acta Neuropathol; 2014 Aug; 128(2):291-303. PubMed ID: 24839957
[TBL] [Abstract][Full Text] [Related]
12. MYCN amplification predicts poor outcome for patients with supratentorial primitive neuroectodermal tumors of the central nervous system .
Gessi M; von Bueren A; Treszl A; zur Mühlen A; Hartmann W; Warmuth-Metz M; Rutkowski S; Pietsch T
Neuro Oncol; 2014 Jul; 16(7):924-32. PubMed ID: 24470553
[TBL] [Abstract][Full Text] [Related]
13. Aberrant promoter methylation of previously unidentified target genes is a common abnormality in medulloblastomas--implications for tumor biology and potential clinical utility.
Frühwald MC; O'Dorisio MS; Dai Z; Tanner SM; Balster DA; Gao X; Wright FA; Plass C
Oncogene; 2001 Aug; 20(36):5033-42. PubMed ID: 11526488
[TBL] [Abstract][Full Text] [Related]
14. A new pineoblastoma cell line, PER-480, with der(10)t(10;17), der(16)t(1;16), and enhanced MYC expression in the absence of gene amplification.
Kees UR; Spagnolo D; Hallam LA; Ford J; Ranford PR; Baker DL; Callen DF; Biegel JA
Cancer Genet Cytogenet; 1998 Jan; 100(2):159-64. PubMed ID: 9428362
[TBL] [Abstract][Full Text] [Related]
15. Molecular analysis of pediatric CNS-PNET revealed nosologic heterogeneity and potent diagnostic markers for CNS neuroblastoma with FOXR2-activation.
Korshunov A; Okonechnikov K; Schmitt-Hoffner F; Ryzhova M; Sahm F; Stichel D; Schrimpf D; Reuss DE; Sievers P; Suwala AK; Kumirova E; Zheludkova O; Golanov A; Jones DTW; Pfister SM; Kool M; von Deimling A
Acta Neuropathol Commun; 2021 Feb; 9(1):20. PubMed ID: 33536079
[TBL] [Abstract][Full Text] [Related]
16. The role of the WNT/β-catenin pathway in central nervous system primitive neuroectodermal tumours (CNS PNETs).
Rogers HA; Ward JH; Miller S; Lowe J; Coyle B; Grundy RG
Br J Cancer; 2013 May; 108(10):2130-41. PubMed ID: 23591193
[TBL] [Abstract][Full Text] [Related]
17. MEK Inhibitors Reverse Growth of Embryonal Brain Tumors Derived from Oligoneural Precursor Cells.
Modzelewska K; Boer EF; Mosbruger TL; Picard D; Anderson D; Miles RR; Kroll M; Oslund W; Pysher TJ; Schiffman JD; Jensen R; Jette CA; Huang A; Stewart RA
Cell Rep; 2016 Oct; 17(5):1255-1264. PubMed ID: 27783941
[TBL] [Abstract][Full Text] [Related]
18. Primitive neuroectodermal tumors of the cerebrum and cerebellum: absence of t(11;22) translocation by RT-PCR analysis.
Jay V; Pienkowska M; Becker L; Zielenska M
Mod Pathol; 1995 Jun; 8(5):488-91. PubMed ID: 7675766
[TBL] [Abstract][Full Text] [Related]
19. Supratentorial primitive neuroectodermal tumors of the central nervous system frequently harbor deletions of the CDKN2A locus and other genomic aberrations distinct from medulloblastomas.
Pfister S; Remke M; Toedt G; Werft W; Benner A; Mendrzyk F; Wittmann A; Devens F; von Hoff K; Rutkowski S; Kulozik A; Radlwimmer B; Scheurlen W; Lichter P; Korshunov A
Genes Chromosomes Cancer; 2007 Sep; 46(9):839-51. PubMed ID: 17592618
[TBL] [Abstract][Full Text] [Related]
20. Somatic mutations of WNT/wingless signaling pathway components in primitive neuroectodermal tumors.
Koch A; Waha A; Tonn JC; Sörensen N; Berthold F; Wolter M; Reifenberger J; Hartmann W; Friedl W; Reifenberger G; Wiestler OD; Pietsch T
Int J Cancer; 2001 Aug; 93(3):445-9. PubMed ID: 11433413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
